Yan Zhou

Prof. Yan Zhou


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2021 in Small
Verified
Journal Article
Closed access
PDF file
FCFangjie Chen
Fangjie Chen
ZGZhongmin Geng
Zhongmin Geng
LWLu Wang
Lu Wang
YZYan Zhou
Yan Zhou
Jinyao LiuJinyao Liu
Jinyao Liu

30 November 2023 in Advanced Science
Verified
Journal Article
Open access
HJHejin Jiang
Hejin Jiang
ZCZhenping Cao
Zhenping Cao
YLYing Liu
Ying Liu
RLRui Liu
Rui Liu
YZYan Zhou
Yan Zhou
Jinyao LiuJinyao Liu
Jinyao Liu
Bacteria can colonize a variety of in vivo biointerfaces, particularly the skin, nasal, and oral mucosa, the gastrointestinal tract, and the reproductive tract, but also target specific lesion sites, such as tumor and wound. By virtue of their prominent characteristics in motility, editability, and targeting ability, bacteria carrying imageable agents are widely developed as living probes for bioimaging and diagnosis of different diseases. This review first introduces the strategies used for preparing bacteria‐based living probes, including biological engineering, chemical modification, intracellular loading, and optical manipulation. It then summarizes the recent progress of these living probes for fluorescence imaging, near‐infrared imaging, ultrasonic imaging, photoacoustic imaging, magnetic resonance imaging, and positron emission tomography imaging. The biomedical applications of bacteria‐based living probes are also reviewed particularly in the bioimaging and diagnosis of bacterial infections, cancers, and intestine‐associated diseases. In addition, the advantages and challenges of bacteria‐based living probes are discussed and future perspectives are also proposed. This review provides an updated overview of bacteria‐based living probes, highlighting their great potential as a unique yet versatile platform for developing next‐generation imageable agents for intelligent bioimaging, diagnosis, and even therapy.

16 March 2021 in Advanced Science
Verified
Journal Article
Open access
PDF file
SWShiman Wu
Shiman Wu
XMXianfu Meng
Xianfu Meng
XJXingwu Jiang
Xingwu Jiang
YWYelin Wu
Yelin Wu
SZShaojie Zhai
Shaojie Zhai
ZYZhenwei Yao
Zhenwei Yao
Timely detection of liver fibrosis by X‐ray computed tomography (CT) can prevent its progression to fatal liver diseases. However, it remains quite challenging because conventional CT can only identify the difference in density instead of X‐ray attenuation characteristics. Spectral CT can generate monochromatic imaging to specify X‐ray attenuation characteristics of the scanned matter. Herein, an X‐ray energy‐dependent attenuation strategy originated from bismuth (Bi)‐based nanoprobes (BiF3@PDA@HA) is proposed for the accurate diagnosis of liver fibrosis. Bi element in BiF3@PDA@HA can exhibit characteristic attenuation depending on different levels of X‐ray energy via spectral CT, and that is challenging for conventional CT. In this study, selectively accumulating BiF3@PDA@HA nanoprobes in the hepatic fibrosis areas can significantly elevate CT value for 40 Hounsfield units on 70 keV monochromatic images, successfully differentiating from healthy livers and achieving the diagnosis of liver fibrosis. Furthermore, the enhancement produced by the BiF3@PDA@HA nanoprobes in vivo increases as the monochromatic energy decreases from 70 to 40 keV, optimizing the conspicuity of the diseased areas. As a proof of concept, the strategically designed nanoprobes with energy‐dependent attenuation characteristics not only expand the scope of CT application, but also hold excellent potential for precise imaging‐based disease diagnosis.

1 February 2021 in Aging
Verified
Journal Article
Open access
NZNan Zhi
Nan Zhi
LZLei Zhang
Lei Zhang
YWYao Wang
Yao Wang
SBShuwei Bai
Shuwei Bai
JGJieli Geng
Jieli Geng
YGYang-Tai Guan
Yang-Tai Guan
We conducted a cross-sectional study to characterize the relationship between total and modified small vessel disease (SVD) score with vascular cognitive impairment (VCI). Patients (n = 157) between the ages of 50 and 85 years old who had suffered their first lacunar infarction were analyzed prospectively. Brain magnetic resonance imaging was performed to identify SVD manifestations, which were used to calculate total or modified SVD scores. Neuropsychological assessments measured cognitive function. Spearman correlation analysis demonstrated that the total and modified SVD scores were associated with overall cognition as well as with function in the executive and visuospatial domains. The associations remained significant in linear regression after adjusting for age, sex, education and vascular risk factors. Binary logistic regression and chi-squared trend tests revealed that VCI risk increased significantly with SVD burden based on the modified SVD score. Subsequent chi-squared testing demonstrated that the VCI rate was significantly higher in patients with a modified SVD score of 5-6 than in patients without any SVD burden. Our results suggest that both the total and modified SVD scores show a negative association with cognitive function, but the modified SVD score may be better at identifying patients at high VCI risk.

20 March 2023 in Insights into Imaging
Verified
Journal Article
Open access
PDF file
BCBing-Hua Chen
Bing-Hua Chen
DADong-Aolei An
Dong-Aolei An
CWChong-Wen Wu
Chong-Wen Wu
TYTing Yue
Ting Yue
MBMatthew Bautista
Matthew Bautista
LWLianming Wu
Lianming Wu
Objectives: This study aimed to investigate the influence of microvascular impairment on myocardial characteristic alterations in remote myocardium at multiple time points, and its prognostic significance after acute ST-segment elevation myocardial infarction (STEMI). Methods: Patients were enrolled prospectively and performed CMR at baseline, 30 days, and 6 months. The primary endpoint was major adverse cardiac events (MACE): death, myocardial reinfarction, malignant arrhythmia, and hospitalization for heart failure. Cox proportional hazards regression modeling was analyzed to estimate the correlation between T1 mapping of remote myocardium and MACE in patients with and without microvascular obstruction (MVO). Results: A total of 135 patients (mean age 60.72 years; 12.70% female, median follow-up 510 days) were included, of whom 86 (63.70%) had MVO and 26 (19.26%) with MACE occurred in patients. Native T1 values of remote myocardium changed dynamically. At 1 week and 30 days, T1 values of remote myocardium in the group with MVO were higher than those without MVO (p = 0.030 and p = 0.001, respectively). In multivariable cox regression analysis of 135 patients, native1w T1 (HR 1.03, 95%CI 1.01–1.04, p = 0.002), native30D T1 (HR 1.05, 95%CI 1.03–1.07, p < 0.001) and LGE (HR 1.10, 95%CI 1.05–1.15, p < 0.001) were joint independent predictors of MACE. In multivariable cox regression analysis of 86 patients with MVO, native30D T1 (HR 1.05, 95%CI 1.04–1.07, p < 0.001) and LGE (HR 1.10, 95%CI 1.05–1.15, p < 0.001) were joint independent predictors of MACE. Conclusions: The evolution of native T1 in remote myocardium was associated with the extent of microvascular impairment after reperfusion injury. In patients with MVO, native30D T1 and LGE were joint independent predictors of MACE.

30 July 2025 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
SWSa Wang
Sa Wang
XZXin-Xin Zhao
Xin-Xin Zhao
DTDan Tang
Dan Tang
SLShi-An Li
Shi-An Li
TLTian-Qi Li
Tian-Qi Li
WYWei-feng Yu
Wei-feng Yu
Precise anesthesia is essential to ensure perioperative safety in patients with hepatic encephalopathy (HE) due to severe liver injuries. Hyperammonemia has been implicated as a possible trigger for HE. However, anesthetic sensitivity in HE and the role of hyperammonemia, in the context of anesthetic sensitivity of HE both remain uncertain. We injected male Sprague Dawley rats with thioacetamide (TAA) to induce acute HE. The time to lose and recover the righting reflex induced by either the inhalation anesthetic isoflurane or the intraperitoneal anesthetic propofol, as well as the 50% effective dosage (ED50) of propofol, were recorded to assess anesthetic sensitivity. Furthermore, we investigated the effect of blood ammonia on anesthetic sensitivity of ammonium acetate-induced hyperammonemia. Functional magnetic resonance imaging (fMRI) was used in tandem with the aforementioned models to identify brain areas that participate in the observed changes in behavior. Statistical significance was determined using student’s t-test, Mann-Whitney test, one-way ANOVA and Kruskal-Wallis analysis, where appropriate. Rats with TAA-induced acute HE took significantly reduced latency to lose the righting reflex and significantly prolonged recovery time under both isoflurane and propofol anesthesia. Additionally, the rats with TAA-induced acute HE displayed a reduction in the ED50 for propofol compared to the vehicle group (2.016 [1.787, 2,277] vs. 46.121 [38.853, 51.163] mg/kg). In the two hyperammonemia groups, only the higher concentration group displayed a reduction in isoflurane induction time (53.63 ± 5.418 vs. 105.8 ± 10.49 s, n = 8, p < 0.001) and prolonged awakening time (308.4 ± 31.76 vs. 166.9 ± 15.65 s, n = 8, p < 0.01), and the ED50 for propofol was reduced (38.848 [33.781, 45.983] vs. 45.643 [41.08, 50.694] mg/kg). The fMRI of HE exhibited neural activity fluctuations in multiple brain areas, while the increased neuronal excitability of the cortex of cerebellum was the main alteration in rats with hyperammonemia. Our results indicate that hyperammonemia increases sensitivity to anesthetic drugs in HE. Neuroimaging evidence suggests the brain areas represents by the cerebellum may constitute to hyperammonemia-associated anesthetic hypersensitivity.